Olema Pharmaceuticals, Inc. Insider Transactions
Purchase
Sell
Olema Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Bain Capital Life Sciences Investors, LLC
10 percent owner |
Buy | 300,000 @ $5.76 | $1.73 M | 7,800,000 | 01/08/2025 | 01/13/2025 | |
|
Graham G. Walmsley
Director |
Sell | 700,761 @ $6.75 | $4.73 M | 0 | 12/17/2024 | 12/17/2024 | |
|
Graham G. Walmsley
Director |
Sell | 700,761 @ $6.75 | $4.73 M | 0 | 12/13/2024 | 12/18/2024 | |
|
Harmon Cyrus
Director |
Sell | 7,958 @ $8.66 | $68.92 K | 764,319 | 12/11/2024 | 12/11/2024 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Sell | 17,950 @ $8.66 | $155.45 K | 543,955 | 12/11/2024 | 12/11/2024 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 300 @ $9.39 | $2.82 K | 598,333 | 12/11/2024 | 12/11/2024 | |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER |
Sell | 320 @ $9.39 | $3.01 K | 115,509 | 12/11/2024 | 12/11/2024 | |
|
Bohen Sean
CEO |
Sell | 55,907 @ $8.66 | $484.16 K | 242,929 | 12/11/2024 | 12/11/2024 | |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER |
Sell | 14,202 @ $8.66 | $122.99 K | 115,829 | 12/11/2024 | 12/11/2024 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 13,314 @ $8.66 | $115.30 K | 598,633 | 12/11/2024 | 12/11/2024 | |
|
Harmon Cyrus
Director |
Sell | 179 @ $9.39 | $1.68 K | 764,140 | 12/11/2024 | 12/11/2024 | |
|
Bohen Sean
CEO |
Sell | 1,267 @ $9.39 | $11.90 K | 241,662 | 12/11/2024 | 12/11/2024 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Sell | 406 @ $9.39 | $3.81 K | 543,549 | 12/11/2024 | 12/11/2024 | |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER |
Sell | 13,283 @ $9.37 | $124.46 K | 130,031 | 12/10/2024 | 12/11/2024 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Sell | 16,803 @ $9.37 | $157.44 K | 561,905 | 12/10/2024 | 12/11/2024 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 12,452 @ $9.38 | $116.80 K | 611,947 | 12/10/2024 | 12/11/2024 | |
|
Bohen Sean
CEO |
Sell | 52,328 @ $9.37 | $490.31 K | 298,836 | 12/10/2024 | 12/11/2024 | |
|
Harmon Cyrus
Director |
Sell | 8,256 @ $9.37 | $77.36 K | 772,277 | 12/10/2024 | 12/11/2024 | |
|
Paradigm Biocapital Advisors LP
10 percent owner |
Sell | 1,870,499 @ $14.92 | $27.90 M | 4,720,482 | 08/01/2024 | 08/05/2024 | |
|
Paradigm Biocapital Advisors LP
10 percent owner |
Sell | 529,501 @ $14.92 | $7.90 M | 783,118 | 08/01/2024 | 08/05/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Olema Pharmaceuticals, Inc. FAQ's
The list of insiders at Olema Pharmaceuticals, Inc. includes Harmon Cyrus, Paradigm Biocapital Advisors LP, Kovacs Shane William Charles, Zojwalla Naseem, Myles David C., Bohen Sean, Graham G. Walmsley, Bain Capital Life Sciences Investors, LLC.
Insiders have sold a total of 4.03 M Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 47.33 M sold.
The following insiders have sold Olema Pharmaceuticals, Inc. shares in the last 12 months: Harmon Cyrus ($287.13 K), Paradigm Biocapital Advisors LP ($35.80 M), Kovacs Shane William Charles ($316.70 K), Zojwalla Naseem ($250.46 K), Myles David C. ($234.92 K), Bohen Sean ($986.37 K), Graham G. Walmsley ($9.46 M),
Insiders have purchased a total of 300.00 K Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 1.73 M.
The following insiders have purchased Olema Pharmaceuticals, Inc. shares in the last 12 months: Bain Capital Life Sciences Investors, LLC ($1.73 M),